Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
Cell
|
February 19, 2021
Functional interrogation of DNA damage response variants with base editing screens
Raquel Cuella-Martin, Samuel B Hayward, Xiao Fan, et al.
Molecular Cell
|
September 25, 2018
The BRCT Domains of the BRCA1 and BARD1 Tumor Suppressors Differentially Regulate Homology-Directed Repair and Stalled Fork Protection
David Billing, Michiko Horiguchi, Foon Wu-Baer, et al.
Cell Reports
|
March 30, 2024
BRCA1 and 53BP1 regulate reprogramming efficiency by mediating DNA repair pathway choice at replication-associated double-strand breaks
Daniela Georgieva, Ning Wang, Angelo Taglialatela, et al.
Nature Communications
|
August 1, 2019
Stimulation of CRISPR-mediated homology-directed repair by an engineered RAD18 variant
Tarun S Nambiar, Pierre Billon, Giacomo Diedenhofen, et al.
Molecular Cell
|
September 9, 2017
Replication Fork Slowing and Reversal upon DNA Damage Require PCNA Polyubiquitination and ZRANB3 DNA Translocase Activity
Marko Vujanovic, Jana Krietsch, Maria Chiara Raso, et al.
Molecular Cell
|
June 13, 2023
Oncogenic IDH mutations increase heterochromatin-related replication stress without impacting homologous recombination
Juan-Manuel Schvartzman, Grace Forsyth, Henry Walch, et al.
Genes & Development
|
July 14, 2026
SMARCAL1 is a candidate therapeutic target for ALT-positive tumors
Angelo Taglialatela, Jina Lee, Benura Azeroglu, et al.
Cell Reports
|
March 24, 2023
Arginine shortage induces replication stress and confers genotoxic resistance by inhibiting histone H4 translation and promoting PCNA ubiquitination
Yi-Chang Wang, Andrew A Kelso, Adak Karamafrooz, et al.
Nature Communications
|
June 13, 2020
MCM8IP activates the MCM8-9 helicase to promote DNA synthesis and homologous recombination upon DNA damage
Jen-Wei Huang, Ananya Acharya, Angelo Taglialatela, et al.
Biorxiv : the Preprint Server for Biology
|
February 27, 2026
SMARCAL1 is a candidate therapeutic target for ALT-positive tumors
Angelo Taglialatela, Jina Lee, Benura Azeroglu, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
Cell
|
February 19, 2021
Functional interrogation of DNA damage response variants with base editing screens
Raquel Cuella-Martin, Samuel B Hayward, Xiao Fan, et al.
Molecular Cell
|
September 25, 2018
The BRCT Domains of the BRCA1 and BARD1 Tumor Suppressors Differentially Regulate Homology-Directed Repair and Stalled Fork Protection
David Billing, Michiko Horiguchi, Foon Wu-Baer, et al.
Cell Reports
|
March 30, 2024
BRCA1 and 53BP1 regulate reprogramming efficiency by mediating DNA repair pathway choice at replication-associated double-strand breaks
Daniela Georgieva, Ning Wang, Angelo Taglialatela, et al.
Nature Communications
|
August 1, 2019
Stimulation of CRISPR-mediated homology-directed repair by an engineered RAD18 variant
Tarun S Nambiar, Pierre Billon, Giacomo Diedenhofen, et al.
Molecular Cell
|
September 9, 2017
Replication Fork Slowing and Reversal upon DNA Damage Require PCNA Polyubiquitination and ZRANB3 DNA Translocase Activity
Marko Vujanovic, Jana Krietsch, Maria Chiara Raso, et al.
Molecular Cell
|
June 13, 2023
Oncogenic IDH mutations increase heterochromatin-related replication stress without impacting homologous recombination
Juan-Manuel Schvartzman, Grace Forsyth, Henry Walch, et al.
Genes & Development
|
July 14, 2026
SMARCAL1 is a candidate therapeutic target for ALT-positive tumors
Angelo Taglialatela, Jina Lee, Benura Azeroglu, et al.
Cell Reports
|
March 24, 2023
Arginine shortage induces replication stress and confers genotoxic resistance by inhibiting histone H4 translation and promoting PCNA ubiquitination
Yi-Chang Wang, Andrew A Kelso, Adak Karamafrooz, et al.
Nature Communications
|
June 13, 2020
MCM8IP activates the MCM8-9 helicase to promote DNA synthesis and homologous recombination upon DNA damage
Jen-Wei Huang, Ananya Acharya, Angelo Taglialatela, et al.
Biorxiv : the Preprint Server for Biology
|
February 27, 2026
SMARCAL1 is a candidate therapeutic target for ALT-positive tumors
Angelo Taglialatela, Jina Lee, Benura Azeroglu, et al.
Page
of 3